GREENLAND MINES LTD Effective Tax Rate
GREENLAND MINES LTD (GRML) reported Effective Tax Rate of 0.00% for the 12-month period ending 2025-12-31, per its 10-K/A filed 2026-08-14.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateContinuingOperations · last filed 2026-08-14
- GREENLAND MINES LTD effective income tax rate reconciliation, percent for the quarter ending 2024-03-31 was -66.17%, a 456.14% decline year-over-year.
- GREENLAND MINES LTD effective income tax rate reconciliation, percent for the quarter ending 2023-09-30 was 31.52%, a 135.93% increase year-over-year.
- GREENLAND MINES LTD effective income tax rate reconciliation, percent for the quarter ending 2023-06-30 was 30.76%.
- GREENLAND MINES LTD effective income tax rate reconciliation, percent for the quarter ending 2023-03-31 was 18.58%.
- GREENLAND MINES LTD effective income tax rate reconciliation, percent for fiscal 2025 was 0.00%.
- GREENLAND MINES LTD effective income tax rate reconciliation, percent for fiscal 2024 was 0.00%.
| Period end | Effective Income Tax Rate Reconciliation, Percent | Effective Income Tax Rate Reconciliation, Percent 3 month | Effective Income Tax Rate Reconciliation, Percent 3 month as first filed | Effective Income Tax Rate Reconciliation, Percent 6 month | Effective Income Tax Rate Reconciliation, Percent 7 month | Effective Income Tax Rate Reconciliation, Percent 9 month | Effective Income Tax Rate Reconciliation, Percent 9 month as first filed | Effective Income Tax Rate Reconciliation, Percent 12 month |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | 0.00% 10-K/A · filed 2026-08-14 | |||||||
| 2024-12-31 | 0.00% 10-K/A · filed 2026-08-14 | |||||||
| 2024-03-31 | -66.17% 10-Q · filed 2024-05-23 | |||||||
| 2023-09-30 | 31.52% 10-Q · filed 2023-11-17 | 33.91% 10-Q · filed 2023-11-17 | ||||||
| 2023-06-30 | 30.76% 10-Q · filed 2023-08-21 | 852.52% 10-Q · filed 2023-08-21 | ||||||
| 2023-03-31 | 18.58% 10-Q · filed 2024-05-23 | |||||||
| 2022-09-30 | 13.36% 10-Q · filed 2023-11-17 | 7.07% 10-Q · filed 2022-11-14 | 9.84% 10-Q · filed 2023-11-17 | 13.36% 10-Q · filed 2022-11-14 | ||||
| 2022-08-16 | 1.00% 10-Q · filed 2024-05-23 | |||||||
| 2022-06-30 | 0.00% 10-Q · filed 2023-08-21 | 0.00% 10-Q · filed 2023-08-21 | ||||||
| 2022-03-31 | 0.00% 10-Q · filed 2023-05-24 | |||||||
| 2021-09-30 | 0.00% 10-Q · filed 2022-11-14 | 0.00% 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |